These results, along with a past report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,two aid the strategy of targeting ACKR3 as a unique way to modulate the opioid method, which could open new therapeutic avenues for opioid-related Ailments.